A detailed history of Kesler, Norman & Wride, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kesler, Norman & Wride, LLC holds 1,503 shares of VRTX stock, worth $613,494. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,503
Holding current value
$613,494
% of portfolio
0.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$460.0 - $505.78 $691,380 - $760,187
1,503 New
1,503 $699,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Kesler, Norman & Wride, LLC Portfolio

Follow Kesler, Norman & Wride, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kesler, Norman & Wride, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kesler, Norman & Wride, LLC with notifications on news.